Estrella Immunopharma Stock Market Value
| ESLAW Stock | 0.06 0.03 29.41% |
| Symbol | Estrella |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Estrella Immunopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Estrella Immunopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Estrella Immunopharma.
| 01/01/2025 |
| 03/02/2025 |
If you would invest 0.00 in Estrella Immunopharma on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Estrella Immunopharma or generate 0.0% return on investment in Estrella Immunopharma over 60 days. Estrella Immunopharma is related to or competes with ServiceNow, Molecular Partners, Lipocine, Parker Hannifin, Vacasa, Allient, and Arrow Electronics. More
Estrella Immunopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Estrella Immunopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Estrella Immunopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 21.94 | |||
| Information Ratio | 0.038 | |||
| Maximum Drawdown | 109.16 | |||
| Value At Risk | (31.76) | |||
| Potential Upside | 42.31 |
Estrella Immunopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Estrella Immunopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Estrella Immunopharma's standard deviation. In reality, there are many statistical measures that can use Estrella Immunopharma historical prices to predict the future Estrella Immunopharma's volatility.| Risk Adjusted Performance | 0.0372 | |||
| Jensen Alpha | 0.9325 | |||
| Total Risk Alpha | 1.54 | |||
| Sortino Ratio | 0.0392 | |||
| Treynor Ratio | 0.2001 |
Estrella Immunopharma Backtested Returns
Estrella Immunopharma appears to be out of control, given 3 months investment horizon. Estrella Immunopharma secures Sharpe Ratio (or Efficiency) of 0.0374, which denotes the company had a 0.0374 % return per unit of risk over the last 3 months. By reviewing Estrella Immunopharma's technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please utilize Estrella Immunopharma's Mean Deviation of 12.6, coefficient of variation of 2670.58, and Downside Deviation of 21.94 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Estrella Immunopharma holds a performance score of 2. The firm shows a Beta (market volatility) of 4.18, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Estrella Immunopharma will likely underperform. Please check Estrella Immunopharma's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Estrella Immunopharma's price patterns will revert.
Auto-correlation | -0.6 |
Good reverse predictability
Estrella Immunopharma has good reverse predictability. Overlapping area represents the amount of predictability between Estrella Immunopharma time series from 1st of January 2025 to 31st of January 2025 and 31st of January 2025 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Estrella Immunopharma price movement. The serial correlation of -0.6 indicates that roughly 60.0% of current Estrella Immunopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.6 | |
| Spearman Rank Test | -0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Estrella Immunopharma lagged returns against current returns
Autocorrelation, which is Estrella Immunopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Estrella Immunopharma's stock expected returns. We can calculate the autocorrelation of Estrella Immunopharma returns to help us make a trade decision. For example, suppose you find that Estrella Immunopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Estrella Immunopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Estrella Immunopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Estrella Immunopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Estrella Immunopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Estrella Immunopharma Lagged Returns
When evaluating Estrella Immunopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Estrella Immunopharma stock have on its future price. Estrella Immunopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Estrella Immunopharma autocorrelation shows the relationship between Estrella Immunopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Estrella Immunopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Estrella Stock Analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.